American College of Rheumatology Guidance for the management of pediatric rheumatic disease during the covid-19 pandemic: Version 2

This clinical guidance is presented (as a ‘living document’) in the context of the COVID-19 pandemic and is based on the available literature, indicating that these children do not appear to be at increased risk for susceptibility to SARS–CoV-2 infection.

Source:

Arthritis & Rheumatology